Keith L. Brownlie - Jun 15, 2023 Form 4 Insider Report for Celldex Therapeutics, Inc. (CLDX)

Role
Director
Signature
/s/ Samuel B. Martin, attorney-in-fact for Keith L. Brownlie
Stock symbol
CLDX
Transactions as of
Jun 15, 2023
Transactions value $
$0
Form type
4
Date filed
6/20/2023, 04:11 PM
Previous filing
Jun 17, 2022
Next filing
Jun 17, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CLDX Non-Qualified Stock Option (right to buy) Award $0 +11.3K $0.00 11.3K Jun 15, 2023 Common Stock 11.3K $36.87 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan.